Literature DB >> 18071316

Skp2 regulates the antiproliferative function of the tumor suppressor RASSF1A via ubiquitin-mediated degradation at the G1-S transition.

M S Song1, S J Song, S J Kim, K Nakayama, K I Nakayama, D-S Lim.   

Abstract

The tumor suppressor RASSF1A is inactivated in many human cancers and is implicated in regulation of microtubule stability, cell cycle progression and apoptosis. However, the precise mechanisms of RASSF1A action and their regulation remain unclear. Here we show that Skp2, an oncogenic subunit of the Skp1-Cul1-F-box ubiquitin ligase complex, interacts with, ubiquitinates, and promotes the degradation of RASSF1A at the G1-S transition of the cell cycle. This Skp2-dependent destruction of RASSF1A requires phosphorylation of the latter on serine-203 by cyclin D-cyclin-dependent kinase 4. Interestingly, mutation of RASSF1A-phosphorylation site Ser(203) to alanine results in a delay in cell cycle progression from G1 to S phase. Moreover, enforced expression of Skp2 abolishes the inhibitory effect of RASSF1A on cell proliferation. Finally, the delay in G1-S progression after Skp2 removal is normalized by depletion of RASSF1A. These findings suggest that the Skp2-mediated degradation of RASSF1A plays an important role in cell proliferation and survival.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18071316     DOI: 10.1038/sj.onc.1210971

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  33 in total

1.  S-phase kinase-associated protein 2 promotes cell growth and motility in osteosarcoma cells.

Authors:  Lu Ding; Rong Li; Rongxin Sun; Yang Zhou; Yubo Zhou; Xiaoping Han; Yong Cui; Wu Wang; Qing Lv; Jingping Bai
Journal:  Cell Cycle       Date:  2017-08-03       Impact factor: 4.534

2.  Ongoing DNA synthesis in the rat cerebral cortex is regulated by a proteolytic pathway independent of the proteasome and calpains.

Authors:  J Sebastián Yakisich; Ake Sidén; Mabel Cruz
Journal:  Invest New Drugs       Date:  2009-03-17       Impact factor: 3.850

3.  The tumour suppressor RASSF1A promotes MDM2 self-ubiquitination by disrupting the MDM2-DAXX-HAUSP complex.

Authors:  Min Sup Song; Su Jung Song; So Yeon Kim; Hyun Jung Oh; Dae-Sik Lim
Journal:  EMBO J       Date:  2008-06-19       Impact factor: 11.598

4.  Targeted polyubiquitylation of RASSF1C by the Mule and SCFβ-TrCP ligases in response to DNA damage.

Authors:  Xin Zhou; Ting-Ting Li; Xu Feng; Esther Hsiang; Yue Xiong; Kun-Liang Guan; Qun-Ying Lei
Journal:  Biochem J       Date:  2012-01-01       Impact factor: 3.857

5.  MEK inhibitor effective against proliferation in breast cancer cell.

Authors:  Yan Zhou; Hai-Yan Hu; Wei Meng; Ling Jiang; Xing Zhang; Jing-Jing Sha; Zhigang Lu; Yang Yao
Journal:  Tumour Biol       Date:  2014-06-18

6.  Cullin-4A·DNA damage-binding protein 1 E3 ligase complex targets tumor suppressor RASSF1A for degradation during mitosis.

Authors:  Lingyan Jiang; Rong Rong; M Saeed Sheikh; Ying Huang
Journal:  J Biol Chem       Date:  2011-01-04       Impact factor: 5.157

Review 7.  Deregulation of F-box proteins and its consequence on cancer development, progression and metastasis.

Authors:  Jinho Heo; Rebeka Eki; Tarek Abbas
Journal:  Semin Cancer Biol       Date:  2015-09-30       Impact factor: 15.707

8.  Cullins and cancer.

Authors:  Jennifer Lee; Pengbo Zhou
Journal:  Genes Cancer       Date:  2010-07

9.  Skp2 deficiency inhibits chemical skin tumorigenesis independent of p27(Kip1) accumulation.

Authors:  Christopher Sistrunk; Sun Hye Kim; Xian Wang; Sung Hyun Lee; Yongbaek Kim; Everardo Macias; Marcelo L Rodriguez-Puebla
Journal:  Am J Pathol       Date:  2013-03-06       Impact factor: 4.307

10.  Methylation associated inactivation of RASSF1A and its synergistic effect with activated K-Ras in nasopharyngeal carcinoma.

Authors:  Tao Wang; Hongli Liu; Yeshan Chen; Wei Liu; Jing Yu; Gang Wu
Journal:  J Exp Clin Cancer Res       Date:  2009-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.